The short version.
If you read nothing else, read this. The whole guide in a handful of bullets.
- What it is: Thymosin alpha-1 is a synthetic copy of a natural 28-amino-acid peptide your thymus makes to train and balance the immune system.
- What people run it for: immune resilience, getting over frequent infections, and supportive care alongside recovery, often with BPC-157.
- Typical dose: about 1.6 mg by subcutaneous injection twice a week, spaced 3 to 4 days apart, mirroring the human trials.
- Routes: subcutaneous injection is the standard. It is not a meaningful oral peptide.
- Cycle: commonly run in cycles, twice weekly, with some people doing a short daily course during an active infection.
- Honest caveat: the same molecule is an approved drug (thymalfasin) studied in large human trials, but the research vials vendors sell are not that medicine and are sold for research use only. This is not medical advice.
Quick reference.
| Typical dose | 1.6 mg, twice weekly |
|---|---|
| Routes | Subcutaneous injection (standard) |
| Frequency | Twice a week, 3 to 4 days apart |
| Cycle length | Run in cycles; short daily course possible during infection |
| Best for | Immune resilience, frequent infections, recovery support |
What is Thymosin α-1?
Thymosin alpha-1 is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. It is a synthetic copy of a natural peptide your thymus, a small gland behind the breastbone, already produces to help run the immune system.
Your thymus is where immune T-cells mature, and thymosin alpha-1 is one of the signals it uses to help those cells learn to recognize threats. As people age and the thymus shrinks, levels of this peptide fall, which is part of why researchers became interested in supplementing it.
The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a hormone, and not a stimulant. People reach for it for one theme above all: a better-balanced, more resilient immune system, rather than a quick energy or muscle effect.
Worth saying plainly: the exact same molecule is an approved medicine in several countries, sold as thymalfasin under the brand Zadaxin, and studied in large human trials for hepatitis and as supportive care. But the research-grade vials vendors sell are not that approved product. They are sold strictly for research use only, and most general immune-support use is off-label. We get into what that means further down.
How it works in the body.
You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.
The core idea is that thymosin alpha-1 works as an immune modulator, meaning it helps balance the immune response rather than just flooring the accelerator. It does this through a few overlapping mechanisms that show up repeatedly in the research.
- Wakes up the immune scouts. It activates Toll-like receptors (TLR2 and TLR9) on dendritic cells and macrophages, the cells that patrol for threats. This helps those cells mature so they can present threats to the rest of the immune system.
- Trains T-cells. It pushes the development of T-cells toward a Th1 response, which strengthens cell-mediated immunity, the arm of the immune system that deals with viruses and infected cells.
- Balances, not just boosts. Because it is a modulator, it is studied for both turning an under-active response up and calming an overactive, inflammatory one, which is why it has been trialled in conditions on both ends of that spectrum.
How to take it: routes of administration.
Thymosin alpha-1 is an injectable peptide. It is not a meaningful oral option, so the real choice is just where you inject, and the honest answer is that one route does almost all the work. Here is the comparison.
| Route | Typical dose | Absorption | Best for | Difficulty |
|---|---|---|---|---|
| Subcutaneous | 1.6 mg | Reliable, systemic | Immune support, standard use | Tiny needle, easy to learn |
| Intramuscular | 1.6 mg | High, systemic | Rarely needed | More invasive, uncommon |
| Oral | Not practical | Very low | Not recommended | Poorly absorbed |
Subcutaneous injection
The standard route by far, and the one used in the human trials. A tiny insulin needle goes into the fat just under the skin, not into muscle. Because thymosin alpha-1 acts on the immune system body-wide, a simple subcutaneous shot into the belly works well, and it is far less intimidating than it sounds.
Intramuscular
Intramuscular injection is possible but rarely necessary for this peptide, since the subcutaneous route is what the clinical evidence is built on. The needle goes deeper and it is a bit more uncomfortable, with no clear advantage here.
Oral
Thymosin alpha-1 is a peptide that does not survive digestion well, so it is not a practical oral option and the capsule versions are not worth chasing. Stick to the injectable form.
Where to inject.
If you go this route, these are the sites people use. Rotate so no single area gets sore.
The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.
So which should a beginner pick? For essentially everyone, subcutaneous is the answer: it is the route the human research used, absorption is reliable, and the needle is tiny. There is no real reason to choose intramuscular or to chase oral versions.
Reconstitution: mixing it.
Thymosin alpha-1 arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.
Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand.
- Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
- Add the water slowly, down the inside wall of the vial. A common mix is a 5 mg vial plus 2 mL of BAC water, which gives a concentration of 2.5 mg/mL.
- Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
- Store it in the fridge once mixed, and keep it out of direct light.
Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 5 mg vial mixed with 2 mL of BAC water gives 2.5 mg/mL, so a 1.6 mg dose is 0.64 mL, which is about 64 units on a U-100 insulin syringe, and that vial holds about 3 doses.
Dosing by goal.
Because thymosin alpha-1 is an approved medicine in some countries, there is actually a well-studied dose to anchor to, which is unusual for a research peptide. What follows is that clinical dose plus the patterns people commonly run.
Standard twice-weekly
The dose used across the large hepatitis trials is 1.6 mg by subcutaneous injection twice a week, with the two shots spaced 3 to 4 days apart, for example Monday and Thursday. This is the best-evidenced pattern.
Active-infection course
Some people run a short daily course of around 1.6 mg when they feel an infection coming on or are actively fighting one, then drop back to the twice-weekly pattern or stop. This mirrors how it has been used as acute supportive care.
Stacked with BPC-157
Thymosin alpha-1 is often run alongside BPC-157 for people who get sick often, since a large share of immune activity lives in the gut. The thymosin schedule stays twice weekly; BPC-157 is dosed daily, so the two run on different rhythms in the same block.
Twice-weekly dosing, 3 to 4 days apart, mirroring the human trials. This is the everyday maintenance pattern.
A short daily course when actively fighting an infection, then back to twice weekly or stop. Used as acute support, not run indefinitely.
Cycling and timing.
A cycle just means a defined run of time on the peptide, followed by a break. For thymosin alpha-1 the common pattern is a focused block of twice-weekly dosing, sometimes with a short daily course during an illness, rather than running it indefinitely.
Why not just run it forever? Mostly because long-term self-directed use outside the studied medical settings has not been characterized. The cautious approach is to run a focused block, then reassess with a provider.
- Hold the schedule through your block, twice a week, spaced 3 to 4 days apart.
- Use the daily course sparingly, only around an active infection, then step back to twice weekly.
- Take a real break after a cycle before considering another. If you are managing a chronic condition, that is a conversation for a licensed provider.
Stacking Thymosin α-1.
Thymosin alpha-1 is an immune peptide, so it is paired with compounds that complement immune resilience and recovery, not with tissue-repair blends.
Immune resilience
The everyday support pair. Thymosin alpha-1 modulates the immune response, while BPC-157 supports the gut lining, where a large share of immune activity lives. The combination people reach for when they get sick too often.
View stack →Healing & immunity
Layers immune support on top of the classic soft-tissue repair pair. A popular step up for people who want recovery and immune resilience covered at once, during a hard training block or while bouncing back from illness.
View stack →See full recipes, dosing, and how people run them on the stacks page.
Side effects and safety.
In the reports we see, and in the clinical trials of the approved version, thymosin alpha-1 is generally described as well tolerated, with side effects that tend to be mild and temporary when they show up at all. The ones people mention most often are:
- Injection-site irritation, a little redness or a small bump, which is why rotating sites matters.
- Mild fatigue reported by some people early in a course.
- Headache occasionally mentioned shortly after a dose.
- Transient joint or muscle aches, which some users describe early on.
Who should be cautious.
Some people have clear reasons to be extra careful, or to avoid thymosin alpha-1 entirely until they have spoken with a licensed provider.
- Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
- Organ transplant recipients or people on immunosuppressants. Because it modulates immune activity, it could in theory interfere with deliberately suppressed immunity. This is strictly a conversation for your transplant team.
- Active autoimmune disease. Anything that shifts immune signaling deserves caution here, so talk to your specialist first.
- Anyone on other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first.
And the universal one: whoever you are, talk to a licensed healthcare provider before starting thymosin alpha-1. This guide is educational, not a substitute for personalized medical advice.
Where to buy it safely.
This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.
- Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
- Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
- Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
- Be skeptical of suspiciously cheap listings with no testing behind them.
That is exactly the comparison we put together. On our Thymosin alpha-1 product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.
Questions, answered straight.
Is Thymosin alpha-1 legal?
Thymosin alpha-1 is approved as a medicine (thymalfasin, brand Zadaxin) in several countries, but not in the United States, where the vials vendors sell are offered strictly for research use only. Unlike TB-500, it is not on WADA's prohibited list, so it is not banned for competing athletes. Rules vary by country, so check what applies where you are.
Is it the same as Thymosin Beta-4 or TB-500?
No. Despite the similar name, thymosin alpha-1 is a completely different peptide with a different job. Thymosin alpha-1 modulates the immune system; Thymosin Beta-4 and its fragment TB-500 are about tissue repair and recovery. They are not interchangeable.
How strong is the evidence?
Unusually strong for a research peptide. The same molecule has been through large human trials as an approved drug for hepatitis B and C and studied as supportive care in sepsis and cancer. The catch is that most of that evidence is for specific medical conditions, not for general immune tune-ups in healthy people.
How long until it works?
Effects tend to build over weeks rather than days, and they are subtle, this is not a stimulant. Many people judge it over a full cycle rather than after a single dose.
Does it need refrigeration?
Keep the sealed, freeze-dried vial in the fridge and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within a few weeks. Do not freeze a reconstituted vial.
How do I figure out the dose in units?
Use our calculator. Enter your vial size, how much bacteriostatic water you added, and your target dose, and it tells you exactly how many units to draw on a U-100 syringe. The dosage calculator handles the math for you.